TP53 and neoplasm: To date, the IHC detection of key molecular markers is possible and highly informative: I) using IDH1R132H mutation specific antibody [31]; II) most ATRX mutations result in undetectable ATRX expression by IHC [32]; and III) mutated p53 protein accumulates in the nucleus of tumour cells [33].